As an extension of the conventional quantitative structure activity relationship models, proteochemometric (PCM) modelling is a computational method that can predict the bioactivity relations between multiple ligands and multiple targets. Traditional PCM modelling includes three essential elements: descriptors (including target descriptors, ligand descriptors and cross-term descriptors), bioactivity data and appropriate learning functions that link the descriptors to the bioactivity data. Since its appearance, PCM modelling has developed rapidly over the past decade by taking advantage of the progress of different descriptors and machine learning techniques, along with the increasing amounts of available bioactivity data. Specifically, the new emerging target descriptors and cross-term descriptors not only significantly increased the performance of PCM modelling but also expanded its application scope from traditional protein-ligand interaction to more abundant interactions, including protein-peptide, protein-DNA and even protein-protein interactions. In this review, target descriptors and cross-term descriptors, as well as the corresponding application scope, are intensively summarized. Additionally, we look forward to seeing PCM modelling extend into new application scopes, such as Target-Catalyst-Ligand systems, with the further development of descriptors, machine learning techniques and increasing amounts of available bioactivity data.
Introduction
The emergence of proteochemometric modelling Drug design has proven to be a difficult task because of the unique selectivity between drugs and receptors. Traditional drug design is time-consuming, expensive and labour-intensive; however, it may be assisted or even determined by computer-aided drug design (CADD) [1] . Since C. Hansch et al. established the first quantitative structure activity relationship (QSAR) approach [2] that linked molecular descriptors with activity data using different quantitative functions, it has been widely used for in silico drug discovery in the past half century [3] [4] [5] . However, conventional QSARs considered the interactions of multiple compounds with only one single target; thus, the predictive ability was limited by the amount of data on a specific target. Additionally, it is difficult for conventional QSARs to identify new classes of ligands or new binding patterns of similar compounds outside the training set because they consider only the ligand information [6] . In fact, affinities sometimes vary even among the similar ligands with a similar or identical protein. Those differences are not only caused by the different chemical structures of ligand or target molecules but also by the variation of binding sites. The binding site of a protein target is usually a flexible structure that allows the binding of different ligand molecules [7] . However, in the approach of conventional QSARs, only one target was studied, and mutations at the protein-binding site cannot be described by the molecule descriptors. In that case, at least some information on protein-ligand interactions, such as different binding modes, different binding sites and interaction features between ligand and binding sites, was missed in conventional QSAR models [8] .
To avoid the above shortcomings of QSAR, an approach relying on the description of multiple ligands along with multiple targets to quantitatively analyse their relations was invented and termed proteochemometric (PCM) modelling by Maris Lapinsh et al. in 2001 [9, 10] . As an extension of conventional QSAR modelling, the main advantage of PCM modelling is that it integrates information on both the ligand and target with the interaction information simultaneously. Theoretically, this approach covers the specific interactions among different compounds and individual targets, as QSAR does. Moreover, the ability to study multiple target-ligand interactions makes PCM modelling a widely used tool to study the mechanism of molecular recognition, whether in multiple variants [11] [12] [13] , superfamily- [14, 15] , kinome- [16] and proteome-wide interaction [17] [18] [19] or, even further, in protein target inhibitor screening in pathogenic viruses, such as HIV [20] and major diseases, such as cancer [21] . Furthermore, it can be applied in more extensive scopes, such as peptide-protein interaction [22] [23] [24] , specific protein-protein interaction and antigen-antibody interaction [25] .
What is PCM modelling?
Like conventional QSAR methods, in PCM modelling, information on both the ligand and target must be transformed into descriptors ( Figure 1 ). Moreover, in PCM modelling, cross-terms can be considered to be 'particular substitutes' of a certain interaction [9] and generated by deriving information from both ligand and target molecules [9, 15, 26, 27] or by directly describing the information on the interaction interface [20, 25, 28] . By combining descriptors with bioactivity data, the PCM model can be generated by adopting different machine learning methods such as partial least squares (PLS), support vector machine (SVM), random forest (RF) and logistic regression. This model can be used to predict the bioactivity values of a new ligand with a new target or to fill in the blanks of an unknown relationship between ligand and target. A standard PCM model can be described as follows:
where D L , D T and D L-T represent the ligand descriptor, the target descriptor and cross-term descriptor from the ligand, the target and their interaction, respectively. BA means bioactivity value. In general, to establish a PCM model, information on three aspects is necessary: (1) descriptors of both the ligand and the target, as well as the cross-term descriptors of interaction Figure 1 . Illustration of PCM modelling. In PCM modelling, each ligand and target molecule will be translated into digital descriptors, and the information on ligandtarget interaction will be represented as additional cross-term descriptors. By integrating machine learning approaches with digital descriptors, PCM modelling can be used to fill in the blanks of multiple ligand and target interaction relations. Furthermore, it can be used to predict the bioactivity value of a new ligand with a new target.
information; (2) bioactivity data for multiple compounds on multiple targets; and (3) inductive learning methods, including different functions and learning approaches. The application scopes of PCM modelling are mostly determined by descriptors. In that case, the recent progress in descriptors as well as their corresponding application scopes were the main concerns of this review. In PCM modelling, descriptors are the final definitions of the logical and mathematical procedures that transform chemical and structural information and encode the symbolic representation of a molecule into a series of digital numbers. Therefore, descriptors can provide adequate insight into the interpretation of the molecule properties and at the same time reduce noise. Furthermore, they can be used to predict interesting properties of other molecules. By describing different aspects of proteins, such as atom type [29, 30] , geometric conformation [21] , Z-scale-based physicochemical properties [9, 14, 15, 27] , sequence information [31] [32] [33] and structure information [25, 34, 35] , descriptors can enhance the availabilities of PCM modelling in multiple fields, as intensively summarized in Supplementary Table S1 . Descriptors in PCM modelling include the ligand descriptors, target descriptors and cross-terms descriptors. For the ligand descriptor, mainly designed for compounds such as small molecules and peptides, numerous methods have been used to describe the structural features of molecules since the early years of QSAR [6, [36] [37] [38] . In PCM modelling, binary descriptors [9, 39] , physicochemical descriptors [40] , two-dimensional topological descriptors [37, 41, 42] and structure descriptors [26] have been the most widely used. Recent approaches mostly focus on the development of target descriptors and cross-term descriptors in an effort to extend the application scope of PCM modelling. Considering that most of the ligand descriptors and machine learning techniques have been comprehensively summarized by Gerard [6] and Isidro [8] , in this review, we will concentrate on the recent development of target descriptors and cross-term descriptors.
Progress on target descriptors and cross-term descriptors in PCM modelling

Target descriptor
Types of target descriptor
The main difference between ligand descriptors and target descriptors is that most of the targets are proteins, which have complex three-dimensional (3D) structures. It would be difficult to describe the overall structure of a protein target, and in most cases, only the residues in the binding sites of the protein targets were selected and described. This process is easier if the crystal structure is available or if the most important mutation sites have been identified previously [6] . Initially, target descriptors were designed to describe proteins from the same or similar protein families. Later, as PCM modelling was applied to multiple protein targets, specifically designed target descriptors began to appear. Protein target descriptors can be roughly divided into atom-based descriptors, amino-acid-based descriptors, sequence-based descriptors, conformational structurebased descriptors, network-based descriptors and string descriptors according to what properties they describe.
Atom-based descriptors were mainly designed to distinguish the atom types of molecules. For each standard protein, all atoms in the protein can be classified into 39 atom types using the SMARTS definitions [29] . For each protein, a 39 bit target descriptor can be generated as a series of counts of each atom type [29, 30] .
Amino-acid-based descriptors characterize different aspects of amino acids in protein structures, including amino-acid types, physicochemical properties, structures and geometric properties. In Sunanta's work, binary descriptors were used to describe mutated residues among 581 positions of each penicillin-binding protein 2 (PBP2) monomer. Each of the 75 specific positions of the total 581 contains two types of residues: the wild-type is represented by 0, whereas the mutated type is represented by 1 [43] . Apart from binary descriptors, the most widely used amino-acid-based descriptors are physicochemical (Z-scales) descriptors [9, 15, 44, 45] . These descriptors contain 26 different physicochemical properties of each amino acid, which are further summarized into several essential categories, including hydrophobicity/hydrophilicity (z1), steric/bulk properties and polarizability (z2), polarity (z3) and electronic effects (z4 and z5) [46] . After identifying the binding sites, this descriptor can be used to calculate the physicochemical properties of each residue in the binding sites. In addition to physicochemical properties, structure information can also be added to describe amino-acid features. These descriptors, introduced by Maris [34] , include seven amino-acid properties, five of which are physicochemical properties, including hydrophobicity, normalized van der Waals volume, polarity, polarizability and charge. The remaining two are structure properties, including secondary structure and solvent accessibility. In addition to the above numerical descriptors, string descriptors have also been applied to encode amino acids in PCM modelling. Typical string descriptors applied by Strombergsson involve information regarding the amino-acid composition of the receptor and the active site of the ligand. The 18 receptors were aligned, and the amino acids at the 52 variable sites were used as descriptors. Each receptor was thus encoded into a vector of 52 strings, where each string is a letter code for one amino acid. Together with one real number of bioactivity data, this method can distinguish such binding interactions from non-binding interactions [47] . These descriptors can be combined with non-linear models, such as rough set (RS) modelling, to classify a compound-ligand pair as active or inactive; however, they are unable to perform regression and predict numerical bioactivity values. Sequence-based descriptors were mainly designed to distinguish multiple protein targets by describing their sequence similarity. In several works, protein targets have been described by binary descriptors [17, 40, 43] according to their sequence identities. This descriptor can generally transform the target or mutation sites into binary code with each site set as 1/0 or 1/À1. For example, in Lapinsh's work [40] , the target was split into five segments, with each segment taken from one of four melanocortin receptor types (MC1, MC3, MC4 and MC5), and four descriptors were set. Each descriptor could categorize the MC types of the corresponding segments. For the first descriptor, if the segment was taken from MC1, it would be set as 1, otherwise, À1. Thus, (5 Â 4 ¼) 20 bit binary descriptors were designed for each receptors. Later, sequence-based descriptors were calculated by multiple target alignment. Typical works such as Lainsh's defined a sequential identity matrix to calculate the sequence identities of the transmembrane (TM) regions in four different melanocortin receptors. In these descriptors, each bit represented the sequence identity of two compared melanocortin receptors [26] . Similar descriptors, such as multiple sequence alignment (MSA) fingerprints [48] , sequence similarity descriptors [21] and TM identity descriptors [44] , were designed to describe multiple receptors based on the sequence identity of the target proteins.
Conformational structure-based descriptors focus on the 3D structures or geometric features of the target protein or binding areas. For example, amino-acid sequence autocorrelation (AASA) vectors designed by Michael can model the functional variation and conformational stability of mutants [49] . The calculated AASA vectors encode structural information concerning the entire protein structure, which can be used to represent the degree of similarity between amino-acid sequences on a structural level. Later, both structure similarity descriptors and geometry descriptors were introduced in Wu's work [21] . Structure similarity descriptors calculated by the Protein Comparison Tool [50] can be applied to calculate the pairwise structure identities of target proteins, whereas geometric descriptors are used to describe various bond lengths, bond angles and dihedral angles of the target protein. Most recently, Qiu's work designed a new group of target descriptors by describing antigen-antibody binding areas at the 3D level, which involved both structural and physicochemical features of the protein target [25] . This isometric descriptor used a cylinder model with a shell structure model, which characterized the spatial locations of residues on the protein-protein interface. This process provided a comparable fingerprint for different types of protein and can sensitively describe even the slightly affinity-affected variation at the same time. This study provided a novel idea for target descriptor establishment that may open a new directions in the application of PCM modelling.
Network-based descriptors were designed through adopting several parameters in network analysis to describe the molecular structures of chemical entities, protein interactions or metabolic networks of target. In those works, different protein structure parameters can be derived from a Markov matrix that accounts for electrostatic interactions between amino-acid pairs in the 3D structure of the target and ligand. For example, the Shannon entropy T h k (R), which can be used to describe information about the structure of the drug-target proteins, can be generated as follows [51] :
where, k p j (R) values are the absolute probability with which the effect of the electrostatic interaction propagates from the amino acid i to all surrounding amino acids j and returns to i th after k-steps. If k ¼ 0, the amino acids were considered to be isolated ones in the space, whereas k ¼ 1 or k > 1 referred to direct contact or indirect interactions in the residue network. In addition to Shannon Entropy descriptors, other types of Markov descriptors, such as Markov-Wiener Node descriptors [52] , Markov-Ruü cker indices [53] , Markov-Galvez indices [54] , Markov-Autocorrelation node descriptors [55] and Markov-Harary numbers [56] , can also be used to predict drug-target interactions by describing protein functions. The use of these parameters allows the rapid collection, annotation, retrieval, comparison and structure mining of molecular, macromolecular, supramolecular and non-molecular systems in large databases [57] . In 2013, Gerard tested the performances of 13 widely used amino-acid descriptors for PCM modelling [58, 59] , including three types of Z-scales descriptors (3, 5 and Binned), four types of ProtFP descriptors (PCA3, PCA5, PCA8 and Feature) [48] , BLOSUM [60] , FASGAI [61] , MS-WHIM [62] , ST-scales [63] , T-scales [64] and VHSE [65] to compare the similarities (or differences) within current available amino-acid descriptor sets by converting structure space to property space. These descriptor sets covered types of physicochemical, substitution matrixbased, 3D electrostatic potential, topological and feature-based descriptors. The results of the principal components analysis of different descriptor sets showed that when considering the full descriptor sets, the clustering patterns were different from the ones that only used the first two components, which seemed to cluster based on derivation method [58] . The author indicated that descriptors can be considered to be complementary to each other and should be sampled when creating novel PCM models [58] . Further studies compare the performance of those descriptors in PCM modelling. In this study, the compound descriptors were ECFP_6 circular fingerprints calculated in Pipeline Pilot 8.5 [59] . This 512 bit fingerprint contains the number of connections to an atom, the element type, the charge and the atomic mass related to different chemical substructures [59] . After different types of internal and external validation, it was observed that all PCM modelling approaches could outperform QSAR and allowed ranking of the performance of different benchmarked descriptors. The results further demonstrated that combinations of different descriptors can consistently perform better in different target groups: for example, the combination of feature-based ProtFP with the physicochemical property-based Z-Scales (3) can slightly but consistently improve the model performance, and a similar effect can also be seen by combining the circular fingerprint (feature based) with physicochemical small molecule descriptors for ligands. This phenomenon may illuminate future studies, in that feature-based fingerprint and physicochemical descriptors can be extensively uszed for research on the structural, functional, expressional and interactional profiles of proteins and ligands. Furthermore, it is possible that the comprehensiveness of both protein and ligand descriptors from different perspectives will improve the performance of PCM modelling.
Available tools for descriptor calculation Most of the above descriptors were calculated by available packages of programming platforms such as R, Python and Java. For example, amino acid and full protein sequence descriptors can be calculated with the functions AADescs and SeqDescs, respectively, from the R package camb [66] . This R package can also be used to calculate physicochemical descriptors (PaDEL) with the function GeneratePadelDescriptors and chemical structure descriptors with the function standardizeMolecules, as well as Z-scale descriptors [31, 35] . Another R package, vegan, can be used to generate the distribution of pairwise compound similarities based on the Jaccard distance. For Python, pybel provides a python wrapper for the cheminformatics [67] , which was introduced in several works for encoding molecular structures based on count vectors of heavy atoms and reflecting the topological distance from each heavy atom of a molecule [68, 69] . In 2007, Thornton's group provided a Java software package that can generate shape descriptors for both ligand and protein binding pockets [70] .
In addition to the available packages from different programming platforms, there are several web servers, databases and software programs available for target descriptor calculation. The PROFEAT (protein feature) web server can calculate the structural and physicochemical features of proteins and peptides based on their amino-acid sequences [71, 72] . This server computes >1400 descriptors from an amino-acid sequence. Other open software or web servers, such as the European Molecular Biology Open Software Suite (EMBOSS) [73] , can calculate sequence similarity descriptors, whereas geometry descriptors can be generated by Protein Data Bank (PDB) Geometry: Structure Variance Analysis (found under Geometry of a protein). More recently, Cristina's group constructed a useful web server named Bio-AIMS that can predict protein activity and evaluate drug-protein target interactions and protein-protein interactions by combining the molecular structural information, such as atom connectivity (molecular graphs) or the physicalchemical properties of an atom or groups of atom, with its molecular activity [74] . Additionally, there are tools that can easily generate multiple PCM models, such as the SVMlight package [75] , R package RRegrs [76] and Weka (Data Mining Software in Java) [77] . Detailed information on the website and application programming interface (API) for tools/algorithms used in PCM modelling can be found in Table 1 Cross-term descriptors Types of cross-term descriptors Another important type of descriptor in PCM modelling is crossterms, which were designed to describe the information from both target and ligand. Although cross-terms are not the integrant for PCM modelling, numerous works have indicated that the prediction results can be improved by adding cross-terms to PCM modelling. For early research in PCM modelling, the crossterms were always derived from Multiplication of Ligand and Protein Descriptors (MLPD) [9, 15, 26, 27] . For example, the latest MLPD research produced by Nabu [43] introduced three different types of MLPD, including protein-ligand, protein-protein and ligand-ligand, to establish a PCM model.
Although it was introduced to account for the complementarity of the properties of the interacting entities, a cross-term descriptor can indeed describe the two entities simultaneously. However, the significance of MLPD is not easy to understand [20] . In addition, because both protein descriptors and ligand descriptors have high encoding capacity, the multiplication can exponentially increase the computational time caused by information redundancy. To address this issue, cross-terms not generated by multiplication were developed [20, 25, 28, 29] . For stable binding profiles, such as peptide binding to a major histocompatibility complex (MHC) molecule, for which the binding pocket of the protein and the anchor residues for the peptide were determined previously [23] , the cross-terms can be generated by considering the information of those key interaction positions on both sides. One PCM analysis applied in peptide binding to the (human leukocyte antigen) HLA-DRB1 super-type generated cross-terms for adjacent peptide positions (L12 block) and peptide-protein cross-terms (LP (Ligand-Protein) block) that describe the amino-acid interactions in pockets 1, 4, 6, 7 and 9 [23] . With the binding affinities of pIC 50 values, the author established a computational server EpiTop for MHC Class II binding prediction [80] .
For cases with different binding profiles, a new set of crossterms called the protein-ligand interaction fingerprint (PLIF) [81- Network-based target descriptor -In-house software (not online) MLPD [9, 14, 15] Multiplication-based cross-term descriptorLocal source (Not online) SIFT [78] Interaction fingerprint-based cross-term descriptor Python http://www.sciencedirect.com/science/article/ pii/S0960894X11012625 EPIF [25] Interaction fingerprint-based cross-term descriptor Python Local source (not online) MOE (PLIF) [20, 28] Interaction fingerprint-based cross-term descriptor 83] was introduced in PCM modelling. These descriptors directly describe the binding interface by summarizing the interactions between ligands and proteins into a fingerprint scheme involving six interaction types: side-chain hydrogen bonds (donor or acceptor), backbone hydrogen bonds (donor or acceptor), ionic interactions and surface interactions in which the residues may participate [20] . These types can be considered suitable crossterm descriptors for computational use (not containing a high capacity of redundant information such as MLPD) and for understanding the meaning of each digital number. Additionally, several studies have indicated that PLIF could significantly improve the model performance and outperform the traditional MLPDbased cross-term descriptors [20] . Furthermore, PLIF could improve both the resolution and predictive ability of PCM modelling and consequently have the potential for broad application [20, 28] . Another group of cross-term descriptors applied in antigenantibody interaction encoded the features of the interaction into a new epitope-paratope interaction fingerprint called EPIF. These cross-term descriptors can be considered as an extension of PLIF because of adding more features that are crucial for characterizing antigen-antibody interactions [25] . Corresponding application cases can be found in the section 'Application scopes of PCM modelling'.
Cross-term descriptor calculation
As most of the cross-term descriptors available now are multiplication-based descriptors, we only focus on specifically designed cross-term descriptors. In Ivan's work, cross-terms for peptide/ protein amino-acid interactions in each pocket were included in the X matrix and formed the LP block of variables. The whole X matrix consisted of six blocks of descriptors, including L, L12, L13, L123, P and LP [23] . In Qiu's work, EPIFs were generated as crossterms. These 15 bit descriptors characterized eight different types of interactions including backbone, side chain, polar, hydrophobic, H-bond receptor, H-bond donor, aromaticity and charge. The first bit represents the existence of any contact: if the first bit is 0, all other 14 are 0. For six strong interaction types, backbone, side chain, polar, hydrophobic, aromatic and charged, an additional bit was included to describe the interaction intensity of the certain position [25] . Apart from the self-designed cross-term descriptors, other popular cross-term PLIF descriptors can be generated by commercial software such as MOE.
Application scopes of PCM modelling
PCM modelling has a wide application scope based on categories of protein targets, such as G protein-coupled receptors (GPCRs) [40, 44, 45] , and enzymes, including kinases [16, 33, 84] , proteases [20, 22, 24] , transcriptases [13, 85] , and immunoglobulins [25, 85] . The application scopes of different target-ligand interactions can be divided into protein-small molecule interactions and protein-macromolecule interactions, which are summarized in Table 2 . More detailed information can be found in Supplementary Table S1 .
Protein-small molecule interactions
GPCRs At the beginning, in silico studies were confined by limited experimental data. For early PCM modelling, GPCRs were the hotspot target for researchers, benefiting from the available bioactivity data [6, 8] . As the target proteins shared similar structures, it was easy to characterize their features. Most of them adopted the widely used physicochemical (Z-scale) target descriptors with Residue frequency [18] , Atom counts [30] , Atom type [29] , Protein sequence and structure [35] , Binding-site shape [96] String [47] Structural and Physicochemical fingerprint [25] Cross-term descriptor Widely used Multiplication [9, 14, 15, 26, 27] , Non [45, 48] Multiplication [11, 12, 86] , Non [32, 87] Multiplication [16, 33] , Non [84] Multiplication [13] , Non [85, 87] Multiplication [17, 21, 88] , Non [31, 34] Non [69, 90] , Multiplication [43, 89] Non [18, 30, 35, 96] Non [98] , Multiplication [22, 24, [91] [92] [93] [94] Specifically used PLIF [82] TAI matrix [49] , PLIF [28] Distance-dependent protein ligand atom type pairs [29] Pocket residue interaction [23] EPIF [25] multiplication-based cross-term descriptors [9, 14, 15, 27, 44] . However, specific custom-designed descriptors also came into play. To characterize individual features of multiple GPCR targets such as subtypes of melanocortin receptors (MC 1 , MC 3 , MC 4 , MC 5 ), Maris Lapinsh calculated a sequential identity matrix to describe the similarities within the above four subtypes [26] . Van Westen's work focused on adenosine receptors and designed an MSA fingerprint for each target based on its crystal structure [29] . In Gao's work, other than using the widely used Z-scale fingerprint, new TM identity descriptors were also added to describe the TM regions of the target proteins [44] .
Enzymes Later, with the growing amounts of available bioactivity data, numerous enzyme targets, including proteases [11, 12, 20, 32, 86, 87] , kinases [16, 33, 84] , reverse transcriptase [13, 85, 87] and other enzyme targets [17, 21, 28, 88, 95] , attracted research attention. In this period, specifically designed target descriptors and cross-term descriptors developed rapidly. For target descriptors, researchers tend to describe the amino-acid composition [32, 95] , full sequence information [33, 49, 84] and geometric shape [21] of the protein target. In 2012, Wu's work introduced three new groups of target descriptors, including sequence similarity descriptors, structure similarity descriptors and geometric descriptors, to characterize five histone deacetylase (HDAC) isoforms. The sequence identities of the five selected HDAC isoforms and all of the HDAC isoforms in the data set have been calculated by EMBOSS [73] , and the protein structure alignment was generated by Protein Comparison Tools from RSCB PDB [50] . More importantly, geometric information concerning various bonds, such as C-N, C-O, C-N-CA and CA-C-O, was measured based on bond length, bond angle and dihedral angle, and 30 protein geometry descriptors were obtained for each HDAC protein. By combining three different target descriptors with cross-term descriptors, they successfully analysed the inhibitory activity of 1275 compounds on five HDAC isoforms simultaneously. Among these models, the best model that integrated structure similarity descriptors with corresponding cross-term descriptors achieved high predictive ability (Q test 2 ¼ 0.7542) [21] . This study also illustrated that the optimal model obtained with suitable target descriptors can potentially be used for designing candidate antitumour drugs to selectively target a single HDAC or a specific class of HDAC isoforms [21] . On the other hand, the most exciting development of crossterm descriptors was the introduction of the PLIF. In 2013, PCM modelling was applied to HIV-1 protease and protease inhibitors by introducing PLIF as cross-terms. This research created nine PCM models with different combinations of ligand descriptor, target descriptor and PLIF to test the performance of different PCM models. The results indicated that the PLIF-based cross-term descriptors, in combination with 32-dimensional general descriptors and the 28-dimensional Drug-Like Index, can achieve better prediction results (
The author indicated that when cross-terms were introduced into PCM modelling, PLIF could always improve the model performance significantly and had a better predictive ability than the conventional MLPC. Further, PLIF could improve the resolution and predictive ability of the PCM model and consequently have potential applications in solving HIV-1 drug-resistance problems [20] . Similar research was applied to describe 153 X-ray crystal protein-ligand structures of human b-site amyloid precursor protein-cleaving enzyme 1 with IC 50 values [28] . After the initial modelling and data processing, a statistically superior model was obtained with 38 PLIF descriptors as x-variables. The high predictability of the test set (R pred 2 ¼ 0.63), the external test set (R pred 2 ¼ 0.69) and the additional validation set (R pred 2 ¼ 0.73) suggests that the model can be popularized in virtual screening [28] .
Specific protein families
Meanwhile, other than GPCRs and enzymes, other specific protein families were also analysed by PCM modelling. In Shardul's work, the target proteins of Plasmodium falciparum and Toxoplasma gondii were analysed, and the most predictive PCM model produced R 0 text 2 and (Root-Mean-Square Error) RMSE test values of 0.79 and 0.59 pIC 50 unit, respectively, outperforming models based exclusively on compound and target information [69] . For penicillin-binding protein 2 of Neisseria gonorrhoeae, Sunanta's group achieved an excellent predictability (
Ext ¼ 0.78), as revealed in the generated model [43] . After feature selection, Nantasenamat's work provided the best PCM modelling performance with R [89] . Tom's work predicted inhibitors of target organic anion-transporting polypeptide 1B1 in the test group with high specificity (86%) and sensitivity (78%) [2, 90] . Because of the high homology of these protein families, however, these results did not provide new approaches for descriptors. Physicochemical (Zscale) descriptors, feature-based ProtFP [90] (see section 'Target descriptor') and multiplication-based cross-terms [43, 89] were still adopted in those studies. All of the above works indicated that with the rapid accumulation of public bioactivity data, PCM modelling can be applied to different protein families.
Multiple protein targets
The above studies all focus on protein targets from the same or similar protein families. With the increasing amounts of available bioactivity data in public databases, including multiple protein families such as ChEMBL [97, 98] and PubChem Bioassay [99, 100] , as well as the development of universality descriptors, targets from different families can be analysed. For multiple protein targets from different protein families, widely used target descriptors are no longer applicable for comparison. Early universal descriptors are characterized by features such as amino-acid frequency [18] , atom counts and atom types [29, 30] . The advantage of these descriptors is that they can project information on the target protein into the same dimensional space, although some information may be lost in the projection. Thus, proteins from different families can be compared. The performance proved the applicability of these specific designed descriptors in modelling: the best decision trees in Helena's work could achieve an accuracy of 80% and an area under the receiver operating characteristic (ROC) curve of 0.81 [18] ; Christina's work demonstrated that the scoring functions can be surprisingly good for the entire diverse database (R 2 out-ofbag ¼ 0.48, R p ¼ 0.69, RMSE ¼ 1.44, MUE ¼ 1.14) [29] , and similar good results can be obtained for the (Community StructureActivity Resource) CSAR-NRC HiQ data set [30] . Later, more accurate descriptors were introduced into PCM modelling. For example, global descriptors, such as 3D structure descriptors [35] , can enhance the accuracy of the 3D binding-site kernel, and local descriptors, such as binding site shape descriptors [96] , can achieve 91% accuracy for drug-target association predictions. Because universal descriptors often contain numerous digital numbers, the multiplication-based descriptors would naturally contain redundant information and greatly increase the computation complexity. Thus, most approaches abandoned cross-term descriptors, and Kramer designed distancedependent protein-ligand atom type pairs for interaction information [29] .
Protein-macromolecule interactions
Protein-peptide Another important application scope of PCM modelling involves protein-macromolecule interactions, such as protein-peptide interactions and protein-protein interactions. For proteinpeptide interactions, traditional target descriptors such as the physicochemical (Z-scales) descriptor [91] [92] [93] and binary descriptor [22, 24, 93] were widely used. A new cross-term that describes the pocket residue interactions was designed by Dimitrov [23] . In his work, six different models were established by integrating pocket residue information. The results indicated that the model involving positions P9, P11, P13, P26, P28 and P30 of the HLA-DRB1 proteins achieved the best prediction ability with r pred 2 ¼ 0.530. This study proved that PCM modelling can be applied to different HLA alleles and may increase the prediction accuracy for particular alleles.
Protein-protein
For protein-protein interactions, especially antigen-antibody interactions, because of the diversity of the binding areas in both antigen and antibody proteins, traditional target descriptors and cross-term descriptors are limited in this situation. As the pioneers in this area, Qiu's work adopted a cylinder model with a shell structure model to describe protein structures and encoded the binding area into an isometric fingerprint [25] . This work was further compared using sequence similarity descriptors [26] and geometric structure descriptors [21] , and the results showed that by using antigen and antibody protein descriptors only, the performance of those newly established descriptors (R 
Conclusion and perspectives
The emergence of PCM modelling hash extended the application scope of conventional QSAR methods and provided a new direction of virtual screening. Almost all PCM-related models have been properly validated by both in silico and experimental methods [6, 8] . Furthermore, several PCM modelling approaches have been compared with conventional QSAR methods, and the results indicate that PCM modelling can outperform conventional QSAR methods [31, 69, 95] . To establish a successful PCM model, three elements are needed: descriptors, bioactivity data and learning functions. For machine learning techniques, PLS are most widely used because it is easy to explain the meaning of each parameter. However, with the development of descriptors, some newly emerged descriptors are not linear. In these cases, non-linear machine learning methods, such as neural network [49] , SVM [31, 69] , RF [31, 34] , supporting vector regression [20, 21, 25] and gradient-boosting machines [31, 69] , begin to appear in PCM modelling. Moreover, to fit string descriptors, RS theory has been adopted in PCM modelling [47] . It can be seen that the development of the machine learning field has greatly promoted the progress of PCM modelling.
Descriptors in PCM modelling can be divided into target descriptors, ligand descriptors and cross-term descriptors according to their functions. As the targets in PCM modelling are mostly mutated protein targets [9, 15] , binary and Z-scale based physicochemical descriptors are the most widely used [6] . For different ligand types such as peptides, small molecules and proteins, different ligand descriptors, including onedimensional to three-dimensional (1D$3D) structure descriptors [25, 69] , geometric descriptors [21] , physicochemical descriptors [25] , amino-acid descriptors [18, 95] and protein sequence descriptors [33, 95] , appeared in PCM modelling. Cross-terms were initially designed as the multiplication of target and ligand descriptors, which may contain a high capacity and significantly increase the complexity of computation. Additionally, it has been noted that this information may be captured by non-linear techniques, such as SVM. Thus, multiplication-based cross terms are suitable for linear methods such as PLS if the capacity is not unacceptable for computation. Furthermore, it has been noted that multiplication-based cross terms are not only challenging to understand but also contain redundant information. These issues were solved by new crossterms, such as PLIF [20] and EPIF [25] , which took information directly from the interaction interface. In addition, several studies have indicated that the prediction ability can be enhanced by adding suitable cross-terms [20, 25] .
The application of PCM is mainly limited by the bioactivity data of target-ligand interactions. Only when the bioactivity data of a certain target-ligand interaction are available, can PCM modelling proceed. Moreover, even though the amount of publicly available data is increasing rapidly, it still appears to be enriched in a small number of protein classes, such as GPCRs and kinases, or important disease targets, such as HIV-1 proteases. For target-ligand interactions without available bioactivity data, simulated bioactivity data have been used. These simulated data may affect the accuracy of prediction, similar to the experimental deviations that are caused by different experimental conditions.
In its development in the past decade, PCM modelling has become a mature computational technique that can use digital information on targets and ligands to predict bioactivity values. The latest PCM modelling studies have mostly been applied to protein-small molecule or protein-peptide interactions, although a few still focus on macromolecule interactions, such as protein-peptide [22, 23] or protein-protein interactions [25] . As the bioactivity data increase, it may be possible to cover more protein families with different ligand interaction systems, such as RNA and lipids.
Considering that most in vivo biochemical reactions involve enzyme catalysis, if a model can predict the interaction between target and ligand along with a catalyst, it may be able to simulate in vivo biochemical reactions realistically. An ideational PCM model for a target-ligand interaction with a catalyst is illustrated in Figure 2 . By extracting structural, physicochemical and geometric space information from the ligand, target and catalyst, together with the interaction information as cross-terms, it may be possible for PCM modelling to identify more complicated systems, such as ligand-catalyst-target (L-C-T) reactions. The application of PCM modelling to L-C-T systems could help us to simulate much more realistic in vivo biochemical reactions, including finding new drugs for protein targets and new catalysts to enhance biochemical reactions, which may open new areas of in silico drug design and drug discovery.
Key Points
• As an extension of conventional QSAR modelling, PCM modelling can integrate information on the ligand and target simultaneously with the interaction information. To establish a successful PCM model, three elements are needed: descriptors, bioactivity data and learning functions.
• Early PCM modelling studies were mainly limited by the bioactivity data on target-ligand interaction. As the amount of publicly available data has increased rapidly in recent years, the application scope has been greatly expanded by the development of descriptors and machine learning techniques.
• The recent application scope of PCM modelling includes but is not limited to small moleculeprotein interactions, peptide-protein interactions and even protein-protein interactions, indicating that the PCM modelling methods proposed in this review could have great potential if applied systematically to CADD.
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